DarioHealth Corp Analyst Ratings

DRIONASDAQ
$7.01
0.8613.98%
Last update: Jun 26, 1:37 PM
Consensus Rating1
Buy
Highest Price Target1
$11.00
Lowest Price Target1
$3.00
Consensus Price Target1
$7.03

DarioHealth Analyst Ratings and Price Targets | NASDAQ:DRIO | Benzinga

DarioHealth Corp has a consensus price target of $7.03 based on the ratings of 4 analysts. The high is $11 issued by TD Cowen on May 13, 2026. The low is $3 issued by Litchfield Hills on May 19, 2025. The 3 most-recent analyst ratings were released by Stifel, TD Cowen, and Stifel on May 14, 2026, May 13, 2026, and March 20, 2026, respectively. With an average price target of $10.33 between Stifel, TD Cowen, and Stifel, there's an implied 35.96% upside for DarioHealth Corp from these most-recent analyst ratings.

Analyst Trends and Forecast

1
Mar
1
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Stifel
TD Cowen
Litchfield Hills
Alliance Global Partners

1calculated from analyst ratings

Analyst Ratings for DarioHealth

Loading calendar...

FAQ

Q

What is the target price for DarioHealth (DRIO) stock?

A

The latest price target for DarioHealth (NASDAQ:DRIO) was reported by Stifel on May 14, 2026. The analyst firm set a price target for $10.00 expecting DRIO to rise to within 12 months (a possible 42.65% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for DarioHealth (DRIO)?

A

The latest analyst rating for DarioHealth (NASDAQ:DRIO) was provided by Stifel, and DarioHealth reiterated their buy rating.

Q

When was the last upgrade for DarioHealth (DRIO)?

A

There is no last upgrade for DarioHealth

Q

When was the last downgrade for DarioHealth (DRIO)?

A

There is no last downgrade for DarioHealth.

Q

When is the next analyst rating going to be posted or updated for DarioHealth (DRIO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DarioHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DarioHealth was filed on May 14, 2026 so you should expect the next rating to be made available sometime around May 14, 2027.

Q

Is the Analyst Rating DarioHealth (DRIO) correct?

A

While ratings are subjective and will change, the latest DarioHealth (DRIO) rating was a reiterated with a price target of $10.00 to $10.00. The current price DarioHealth (DRIO) is trading at is $7.01, which is out of the analyst’s predicted range.